Abstract
As reported in a recent paper by Whitehouse and Walker (1978) copper has effective anti-inflammatory (AI)properties. Various copper Cu or Cu”‘“ compounds are currently being synthetized and studied on experimental models of inflammation in order to find an active and altogether innocuous molecule. In human clinic, copper treatment of inflammation was already utilized in the middle of the century by Forestier in France and by Hangarter and Lubke in Germany (reviewed by Sorenson and Hangarter, 1977). Both treatments were given by the intravenous route, not in favor among clinicians. The discovery of cortisone at the same period and progress in the chemistry of non-steroidal AI compounds put for a while the copper molecules into disuse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bannister J.V., W.H. Bannister, H.A.O. Hill, J.F. Mahood, R.L. Willson and B.S. Wolfenden, FEBS Letters, 118, 127 (1980).
Bragt P.C. and I.L. Bonta, Agents and Actions, 10, 536 (1980).
Chappuis P., Y. Henry, M.J. Laroche and F. Rousselet, C. R. Soc. Biol., 175, 169 (1981).
Clarke H.G.M. and P. Freeman, Clin. Sci., 35, 403 (1968).
Denko C.W., Agents and Actions, 9 333 (1979).
Deutsch H.F., C.B. Kasper and D.A. Walsh, Arch. Biochem. Biophys., 99, 132 (1962).
Dormandy T.L., The Lancet, 1, 647 (1978).
Färheus G. and B. Reinhammar, Acta Chem. Scand., 21, 2367 (1967).
Fee J.A., Structure and Bonding, 23, 1, (1975).
Frieden E. and H.S. Hsieh, Adv. Exper. Med. Biol., 74, 505 (1976).
Goldberg A.S., E.C. Mueller, E. Eigen and S.J. Desalva, J. Pharm. Sci., 58, 938 (1969).
Goldstein I.M., H.B. Kaplan, H.S. Edelson and G. Weissmann, J. Biol. Chem., 254, 4040 (1979).
Guissani A., Y.Henry and L. Gilles, submitted.
Gutteridge J.M.C., R. Richmond and B. Halliwell, FEBS Letters, 112, 269 (1980).
Horn R.A., E.J. Friesen, R.L.S. Stephens, W.R. Hedrick and J.D. Zimbrick, Cancer, 43, 2392 (1979).
Kleinhans F.M., S.C. Kline and W.M. Dugan, Fed. Proc., 39, 1769 (1980).
Laroche M.J., French Patent n° 71. 04295 (1971).
Lewis A.J., W.E. Smith and D.H. Brown, Agents and Actions, 8 Suppl., 327 (1981).
Mc Cord J.M. and I. Fridovich, J. Biol. Chem., 244, 6049 (1969).
Milanino R. and G.P. Velo, Agents and Actions, 8 Suppl. 209 (1981).
Owen C.A., Proc. Soc. Expl. Biol. Med., 149, 681 (1975).
Parr S.R., D. Barber, C. Greenwood, B.W. Phillips and J. Melling, Biochem. J., 157, 423 (1976).
Plonka A., D. Metodiewa, A. Zgirski, M. Hilewicz and W. Leyko, Biochem. Biophys. Res. Comm., 95, 978 (1980).
Reinhammar B., Biochim. Biophys. Acta, 205, 35 (1970).
Robertson P. and I. Fridovich, Arch. Biochem. Biophys., 203, 830 (1980).
Ryden L. and I. Björk, Biochemistry, 15, 341 1 (1976).
Sorenson J.R.J, and W. Hangarter, Inflammation, 2, 217 (1977).
Weser U., Metalloproteins ( Georg Thieme Verlag, Stuttgart ) (1979).
Whitehouse M.W. and W.R. Walker, Agents and Actions, 8, 85 (1978).
Wright G.L., L. Pollack and D.B. Roberts, Clin. Chem., 20, 30 (1974).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 The Humana Press Inc.
About this chapter
Cite this chapter
Laroche, M.J., Chappuis, P., Henry, Y., Rousselet, F. (1982). Ceruloplasmin: Experimental Anti-Inflammatory Activity and Physicochemical Properties. In: Sorenson, J.R.J. (eds) Inflammatory Diseases and Copper. Experimental Biology and Medicine, vol 2. Humana Press. https://doi.org/10.1007/978-1-4612-5829-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5829-2_6
Publisher Name: Humana Press
Print ISBN: 978-1-4612-5831-5
Online ISBN: 978-1-4612-5829-2
eBook Packages: Springer Book Archive